Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence
NCT ID: NCT00262093
Last Updated: 2007-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2005-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection and Identification of Preeclampsia Via Volatile Biomarkers
NCT01291342
Pre-Eclampsia Prediction By Doppler Screening Of Uterine Arteries And Angiogenic Factors In Second Trimester Of Pregnancy
NCT00725660
Hyperspectral Imaging for Prediction of Preeclampsia
NCT07106294
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
NCT01519297
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We intend to check the angiogenesis profile of primiparas as compared to multiparas.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beth Israel Deaconess Medical Center
OTHER
Hadassah Medical Organization
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuval Bdolah, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
Hadassah-Hebrew University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah Medical Organization
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRIMIMULTI-HMO-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.